Reviewed by Michael Gill, B. Sc.
25 Substance Abuse Clinical Trials Near Me
Top Hospitals for Substance Abuse Clinical Trials
Image of University of California, Los Angeles in California.
University of California, Los Angeles
Los Angeles
5Active Trials
9All Time Trials for Substance Abuse
2004First Substance Abuse Trial
Image of Gateway Community Services in Florida.
Gateway Community Services
3Active Trials
8All Time Trials for Substance Abuse
2004First Substance Abuse Trial
Top Cities for Substance Abuse Clinical Trials
Substance Abuse Clinical Trials by Phase of Trial
Phase < 1 Substance Abuse Clinical Trials
1Active Substance Abuse Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
Substance Abuse Clinical Trials by Age Group
< 18 Substance Abuse Clinical Trials
9Active Substance Abuse Clinical Trials
Top Treatments for Substance Abuse Clinical Trials
Treatment Name
Active Substance Abuse Clinical Trials
All Time Trials for Substance Abuse
First Recorded Substance Abuse Trial
Buprenorphine Injection
Repetitive Transcranial Magnetic Stimulation (rTMS)
Contingency Management for Methamphetamine Reduction
Motivational Interviewing at Intake (MII)
Omnis Salutis
Recently Completed Studies with FDA Approved Treatments for Substance Abuse
Non invasive VN stimulation (nVNS)
Emory University
Vivitrol (Extended Release Naltrexone)
University of California, San Francisco
Bictegravir/emtricitabine/tenofovir alafenamide
University of Nebraska
Elizabeth Krans, MD

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: October 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905-17. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998 May;14(4):245-58. Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997 Jul;38(5):581-6. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003 Aug;26(1):1-7. Review. Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007 Jul 19;55(2):187-99. Review. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009 Jun 29;338:b2393. doi: 10.1136/bmj.b2393. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002 Mar;7(1):83-104. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002 Oct 16;288(15):1909-14.